(Fighting against New Coronary Pneumonia) 13.8 yuan a box rose to 46 yuan A company in Inner Mongolia was investigated for driving up the price of Lianhua Qingwen
China News Service, Chifeng, December 10th (Reporter Zhang Linhu) On the 10th, the reporter learned from the Market Supervision and Administration Bureau of Chifeng City, Inner Mongolia Autonomous Region that a local pharmaceutical company was investigated for arbitrarily raising the price of epidemic-related drugs.
It is reported that the Chifeng City Market Supervision Administration received a report that the price of Lianhua Qingwen capsules sold by a local pharmaceutical company has risen much higher than usual.
The law enforcement officers immediately started the case verification procedure, rushed to the scene to fix the evidence, and obtained relevant evidence such as the company's purchase and sales accounts and background sales records.
After investigation, the company significantly increased the sales price of Lianhua Qingwen Capsules without a significant increase in operating costs. box, the price is increased to 46 yuan/box and 55 yuan/box.
The company raised the price of the epidemic-related drugs at will, and the increase was relatively large, disrupting the normal price order of the epidemic-related drug market, and is currently being investigated by the market supervision department.
(Finish)